Ajanta House
98 Govt. Industrial Area Charkop Kandivili (West)
Mumbai 400067
India
91 22 6606 1000
https://www.ajantapharma.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 8 073
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Yogesh Mannalal Agrawal M.B.A | MD & Executive Director | 215,96M | S.O. | 1972 |
Mr. Rajesh Mannalal Agrawal M.B.A | Joint MD & Director | 215,96M | S.O. | 1976 |
Mr. Madhusudan Bhagwandas Agrawal B.Sc | Executive Vice Chairman of the Board | 42,04M | S.O. | 1955 |
Mr. Arvind K. Agrawal | Chief Financial Officer | S.O. | S.O. | 1963 |
Mr. Gaurang Chinubhai Shah | VP of Legal, Company Secretary & Compliance Officer | S.O. | S.O. | S.O. |
Mr. H. Nandkishore Agrawal | President of International Business | S.O. | S.O. | 1960 |
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
L’ISS Governance QualityScore de Ajanta Pharma Limited en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..